Mason Carrico
Stock Analyst at Stephens
(0.68)
# 4,180
Out of 4,712 analysts
56
Total ratings
37%
Success rate
-4.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mason Carrico
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MYGN Myriad Genetics | Rated: Hold | $30 → $3 | $3.19 | -5.96% | 6 | Aug 18, 2026 | |
| GH Guardant Health | Reiterated: Buy | $63 → $195 | $162.78 | +19.79% | 4 | Aug 4, 2026 | |
| VCYT Veracyte | Reiterated: Buy | $32 → $55 | $43.86 | +25.40% | 5 | Aug 4, 2026 | |
| ATEC Alphatec Holdings | Initiated Coverage: Buy | $15 | $8.99 | +66.94% | 1 | Jul 23, 2026 | |
| IRTC iRhythm Holdings | Initiated Coverage: Buy | $160 | $119.57 | +33.81% | 1 | Jul 22, 2026 | |
| CTKB Cytek Biosciences | Rated: Buy | $4 → $4.75 | $4.73 | +0.42% | 3 | May 13, 2026 | |
| ESTA Establishment Labs Holdings | Rated: Buy | $90 | $74.51 | +20.79% | 1 | Feb 25, 2026 | |
| GKOS Glaukos | Reiterated: Buy | $115 → $145 | $179.79 | -19.35% | 2 | Jan 2, 2026 | |
| PACB Pacific Biosciences of California | Reiterated: Buy | $2.5 → $2 | $1.29 | +55.04% | 3 | Nov 10, 2025 | |
| NEO NeoGenomics | Reiterated: Buy | $18 → $11 | $17.66 | n/a | 4 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $156 → $110 | $205.00 | n/a | 8 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $70 | $20.74 | n/a | 1 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $18 | $50.03 | n/a | 7 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $67.29 | n/a | 3 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 | $32.31 | n/a | 3 | May 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $330.31 | n/a | 2 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.1 → $1.25 | $4.10 | n/a | 2 | May 24, 2022 |
Myriad Genetics
Aug 18, 2026
Rated: Hold
Price Target: $30 → $3
Current: $3.19
Upside: -5.96%
Guardant Health
Aug 4, 2026
Reiterated: Buy
Price Target: $63 → $195
Current: $162.78
Upside: +19.79%
Veracyte
Aug 4, 2026
Reiterated: Buy
Price Target: $32 → $55
Current: $43.86
Upside: +25.40%
Alphatec Holdings
Jul 23, 2026
Initiated Coverage: Buy
Price Target: $15
Current: $8.99
Upside: +66.94%
iRhythm Holdings
Jul 22, 2026
Initiated Coverage: Buy
Price Target: $160
Current: $119.57
Upside: +33.81%
Cytek Biosciences
May 13, 2026
Rated: Buy
Price Target: $4 → $4.75
Current: $4.73
Upside: +0.42%
Establishment Labs Holdings
Feb 25, 2026
Rated: Buy
Price Target: $90
Current: $74.51
Upside: +20.79%
Glaukos
Jan 2, 2026
Reiterated: Buy
Price Target: $115 → $145
Current: $179.79
Upside: -19.35%
Pacific Biosciences of California
Nov 10, 2025
Reiterated: Buy
Price Target: $2.5 → $2
Current: $1.29
Upside: +55.04%
NeoGenomics
Sep 2, 2025
Reiterated: Buy
Price Target: $18 → $11
Current: $17.66
Upside: n/a
Aug 4, 2025
Rated: Buy
Price Target: $156 → $110
Current: $205.00
Upside: n/a
Jul 9, 2025
Initiated Coverage: Buy
Price Target: $70
Current: $20.74
Upside: n/a
May 13, 2024
Reiterated: Buy
Price Target: $15 → $18
Current: $50.03
Upside: n/a
May 18, 2023
Reiterated: Buy
Price Target: $65
Current: $67.29
Upside: n/a
May 8, 2023
Reiterated: Buy
Price Target: $41
Current: $32.31
Upside: n/a
Dec 16, 2022
Reiterated: Buy
Price Target: n/a
Current: $330.31
Upside: n/a
May 24, 2022
Downgraded: Hold
Price Target: $3.1 → $1.25
Current: $4.10
Upside: n/a